Relistor - 0008-2513-04 - (Methylnaltrexone bromide)

Alphabetical Index


Drug Information of Relistor

Product NDC: 0008-2513
Proprietary Name: Relistor
Non Proprietary Name: Methylnaltrexone bromide
Active Ingredient(s):    & nbsp;   Methylnaltrexone bromide
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Relistor

Product NDC: 0008-2513
Labeler Name: Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021964
Marketing Category: NDA
Start Marketing Date: 20080801

Package Information of Relistor

Package NDC: 0008-2513-04
Package Description: 2 TRAY in 1 CARTON (0008-2513-04) > 1 KIT in 1 TRAY * .6 mL in 1 VIAL, SINGLE-DOSE * 1 SWAB in 1 PACKET

NDC Information of Relistor

NDC Code 0008-2513-04
Proprietary Name Relistor
Package Description 2 TRAY in 1 CARTON (0008-2513-04) > 1 KIT in 1 TRAY * .6 mL in 1 VIAL, SINGLE-DOSE * 1 SWAB in 1 PACKET
Product NDC 0008-2513
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Methylnaltrexone bromide
Dosage Form Name KIT
Route Name
Start Marketing Date 20080801
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Relistor


General Information